My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Seretide 125 Evohaler 25 microgram/125 microgram/dose pressurised inhalation, suspension



PCO Manufacturing Ltd.PPA0465/091/005

Main Information

Trade NameSeretide 125 Evohaler 25 microgram/125 microgram/dose pressurised inhalation, suspension
Active SubstancesFluticasone propionate
SALMETEROL XINAFOATE
Dosage FormPressurised inhalation, suspension
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/091/005

Group Information

ATC CodeR03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
R03AK06 salmeterol and fluticasone

Status

License statusAuthorised
Licence Issued06/02/2004
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA1077/046/005.
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListSalmeterol/Fluticasone 25mcg/125mcg Pressurised Inhalation Suspension
Interchangeable List CodeIC0128-176-053
Interchangeable List DocumentPDF of Interchangeable List
« Back
Follow medicine

Print